Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Intercept Withdraws Ocaliva From US, The Last Market For The PBC Drug
Removal Was Likely After Multiple Safety Alerts
Sep 11 2025
•
By
Mandy Jackson
Ocaliva already has had its approval revoked in the EU
(Shutterstock)
More from Rare Diseases
More from Scrip